BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1631729)

  • 1. [Seroepidemiology of measles in Mexico].
    Sepúlveda J; Tapia-Conyer R; Valdespino JL; Quiroz G; Salvatierra B; Zárate ML; Magos C; Llausás A; Gutiérrez G
    Salud Publica Mex; 1992; 34(2):148-56. PubMed ID: 1631729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seroepidemiology of poliomyelitis in Mexico].
    Ruiz-Gómez J; Tapia-Conyer R; Salvatierra B; Quiroz G; Magos C; Llausás A; Gutiérrez G; Sepúlveda J
    Salud Publica Mex; 1992; 34(2):168-76. PubMed ID: 1321508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemic measles in a highly vaccinated population.
    Shasby DM; Shope TC; Downs H; Herrmann KL; Polkowski J
    N Engl J Med; 1977 Mar; 296(11):585-9. PubMed ID: 65732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
    Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA
    Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on measles vaccination rate and its antibody level in children aged 12-24 months in Guangxi, 1989].
    Lin M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):138-40. PubMed ID: 1423535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles epidemiology and its implications for a vaccination programme in Oman.
    Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
    East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles antibody titre in children up to 5 years of age in rural areas of Aligarh District, India.
    Khan Z; Malik A; Pal SD; Khan MY
    Saudi Med J; 2000 Feb; 21(2):175-9. PubMed ID: 11533777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G; Boulianne N; Ratnam S; Corriveau A
    Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination.
    Enquselassie F; Ayele W; Dejene A; Messele T; Abebe A; Cutts FT; Nokes DJ
    Epidemiol Infect; 2003 Jun; 130(3):507-19. PubMed ID: 12825737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The seroepidemiology of rubella in Mexican women. A national probability survey].
    Gutíerrez Trujillo G; Muñoz O; Tapia Conyer R; Bustamante Calvillo ME; Alvarez y Muñoz MT; Guiscafré Gallardo JP; Magos C; Sepúlveda J
    Salud Publica Mex; 1990; 32(6):623-31. PubMed ID: 2089638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate age for measles vaccination in the United States.
    Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ
    Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe.
    Obi CL; Tswana SA; Moyo SR; Berejena C
    Cent Afr J Med; 1996 May; 42(5):135-8. PubMed ID: 8771931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.